[Experimental therapy of alveococcosis. II. Effectiveness of some anti-nematode preparations in alveococcosis of laboratory animals].
D000818:Animals; D000923:Anticestodal Agents / Q000627:therapeutic use*; D004049:Diethylcarbamazine / Q000627:therapeutic use; D004225:Dithiazanine / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004443:Echinococcosis / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007814:Larva / Q000187:drug effects; D007928:Lethal Dose 50; D007978:Levamisole / Q000627:therapeutic use; D008463:Mebendazole / Q000627:therapeutic use; D008558:Melphalan / Q000627:therapeutic use; D051379:Mice; D011715:Pyrantel / Q000627:therapeutic use; D051381:Rats; D013827:Thiabendazole / Q000627:therapeutic use
D000923:Anticestodal Agents; D007978:Levamisole; D011715:Pyrantel; D004225:Dithiazanine; D008463:Mebendazole; D013827:Thiabendazole; D008558:Melphalan; D004049:Diethylcarbamazine
Eksperimental'naia terapiia al'veokokkoza. Soobshchenie II. Effectivnost 'pri al'veokokkoze laboratornykh zhivotnykh nekotorykh protivonematodnykh sredst